NOVOGENE CORPORATION INC

PERFORM QUALITY CONTROL OF THE DNA AND RNA THAT IS DE-IDENTIFIED.

PHARMACOGENOMIC ANALYSIS SERVICES OF PARTICIPANTS ENROLLED IN THE STAR-B RANDOMIZED CLINICAL TRIAL OF SEMAGLUTIDE FOR ALCOHOL USE DISORDER

PLANT/ANIMAL STRAND SPECIFIC MRNA SEQUENCING SERVICES

SOLE SOURCE RNA SEQUENCING WITH NOVOGENE CORPORATION VA PALO ALTO RESEARCH

RNASEQ NEBNEXT ULTRA II (DIRECTIONAL) RNA WITH POLYA SELECTION NEXT GENERATION SEQUENCING ILLUMINA 2X150; 6GB ESTIMATED 40M PAIRED END READS (20M IN EACH DIRECTION) PER SAMPLE

PRE-MADE LIBRARY LANE SEQUENCING SERVICES FROM NOVOGENE CORPORATION TO SUPPORT ONGOING WILDLIFE GENOMICS RESEARCH.

VARIOUS SEQUENCING AND ANALYSES FOR SMALL GRAINS.

100 PLANT SAMPLES FOR PLANT EUKARYOTIC MRNA-SEQUENCING

FY26 UDO INITIATIVE PLANT AND ANIMAL EUKARYOTIC MRNA SEQUENCING

FY26 UDO INITIATIVE - THE PURPOSE OF THIS PURCHASE ORDER IS TO ACQUIRE SERVICES FOR TO DO WHOLE GENOME SEQUENCING AND WHOLE GENOME BISULFITE SEQUENCING FOR DNA SAMPLES.

FY26 UDO INITIATIVE PREMADE LIBRARIES AND LANE SEQUENCING NOVASEQ PE 150

FY26 UDO INITIATIVE SEQUENCING SERVICES RELATING TO TICK STUDIES AT RML

CHARACTERIZING GENE EXPRESSION CHANGES IN AQUATIC AND ESTUARINE ORGANISMS EXPOSED TO PRIORITY AND EMERGING CONTAMINANTS USING TRANSCRIPTOMIC ANALYSIS BY MRNASEQ. SEE ATTACHED STATEMENT OF WORK

NOTICE OF TERMINATION FOR CONVENIENCE

SINGLE CELL RNA - DURHAM RESEARCH LABORATORY - VA MEDICAL CENTER

TO ADMINISTRATIVELY DE-OBLIGATE UNEXPENDED AND EXPIRING FISCAL YEAR 2021 FUNDING IN ACCORDANCE WITH 31 U.S.C. SECTION 1552 (A), IN PREPARATION FOR SEPTEMBER 30, 2026, CLOSING OF THE PERIOD OF AVAILABILITY OF THESE FISCAL YEAR FUNDS.

FY26 UDO INITIATIVE - TO ADMINISTRATIVELY DE-OBLIGATE UNEXPENDED AND EXPIRING FISCAL YEAR 2021 FUNDING IN ACCORDANCE WITH 31 U.S.C. SECTION 1552 (A)